684 related articles for article (PubMed ID: 19306808)
21. Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis.
Goeppert B; Stichel D; Toth R; Fritzsche S; Loeffler MA; Schlitter AM; Neumann O; Assenov Y; Vogel MN; Mehrabi A; Hoffmann K; Köhler B; Springfeld C; Weichenhan D; Plass C; Esposito I; Schirmacher P; von Deimling A; Roessler S
Gut; 2022 Feb; 71(2):391-401. PubMed ID: 33468537
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological Aspects and Diagnostic Problems in Patients with Intraductal Papillary Neoplasm of the Bile Duct.
Nanashima A; Imamura N; Sumida Y; Hiyoshi M; Hamada T; Nagayasu T
Anticancer Res; 2018 Apr; 38(4):2343-2352. PubMed ID: 29599359
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic Study of Biliary Intraepithelial Neoplasia in Cholangiocarcinoma.
Kim HJ; Kim JS; Kim BH; Bak YT
Dig Surg; 2018; 35(2):116-120. PubMed ID: 28490009
[TBL] [Abstract][Full Text] [Related]
24. Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct.
Zen Y; Fujii T; Itatsu K; Nakamura K; Konishi F; Masuda S; Mitsui T; Asada Y; Miura S; Miyayama S; Uehara T; Katsuyama T; Ohta T; Minato H; Nakanuma Y
Mod Pathol; 2006 Sep; 19(9):1243-54. PubMed ID: 16741522
[TBL] [Abstract][Full Text] [Related]
25. Precancerous lesions of the biliary tree.
Klöppel G; Adsay V; Konukiewitz B; Kleeff J; Schlitter AM; Esposito I
Best Pract Res Clin Gastroenterol; 2013 Apr; 27(2):285-97. PubMed ID: 23809246
[TBL] [Abstract][Full Text] [Related]
26. Pathological survey of precursor lesions in cholangiocarcinoma.
Nakanuma Y; Sugino T; Kakuda Y; Nomura Y; Watanabe H; Terada T; Sato Y; Ohnishi Y; Fukumura Y
J Hepatobiliary Pancreat Sci; 2023 Jul; 30(7):893-903. PubMed ID: 36707055
[TBL] [Abstract][Full Text] [Related]
27. Latest advances in the pathological understanding of cholangiocarcinomas.
Nakanuma Y; Miyata T; Uchida T
Expert Rev Gastroenterol Hepatol; 2016; 10(1):113-27. PubMed ID: 26492529
[TBL] [Abstract][Full Text] [Related]
28. Pathological spectrum of bile duct lesions from chronic bile duct injury to invasive cholangiocarcinoma corresponding to bile duct imaging findings of occupational cholangiocarcinoma.
Kinoshita M; Kubo S; Nakanuma Y; Sato Y; Takemura S; Tanaka S; Hamano G; Ito T; Terajima H; Yamada T; Nakamori S; Arimoto A; Fujikawa M; Sugawara Y; Yamamoto T; Abue M; Nakagawa K; Unno M; Mizuguchi T; Takenaka K; Shirabe K; Shibata T
J Hepatobiliary Pancreat Sci; 2016 Feb; 23(2):92-101. PubMed ID: 26580863
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is a marker that predicts presence of invasion in papillary biliary tumors.
Sasaki M; Sato Y
Hum Pathol; 2017 Apr; 62():152-159. PubMed ID: 28089541
[TBL] [Abstract][Full Text] [Related]
30. Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary chronic advanced liver diseases.
Nakanuma Y; Xu J; Harada K; Sato Y; Sasaki M; Ikeda H; Kim J; Yu E
Pathol Int; 2011 May; 61(5):298-305. PubMed ID: 21501296
[TBL] [Abstract][Full Text] [Related]
31. A novel approach to biliary tract pathology based on similarities to pancreatic counterparts: is the biliary tract an incomplete pancreas?
Nakanuma Y
Pathol Int; 2010 Jun; 60(6):419-29. PubMed ID: 20518896
[TBL] [Abstract][Full Text] [Related]
32. Premalignant lesions of cholangiocarcinoma: characteristics on ultrasonography and MRI.
Siripongsakun S; Sapthanakorn W; Mekraksakit P; Vichitpunt S; Chonyuen S; Seetasarn J; Bhumiwat S; Sricharunrat T; Srittanapong S
Abdom Radiol (NY); 2019 Jun; 44(6):2133-2146. PubMed ID: 30820627
[TBL] [Abstract][Full Text] [Related]
33. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis.
Igarashi S; Matsubara T; Harada K; Ikeda H; Sato Y; Sasaki M; Matsui O; Nakanuma Y
Histopathology; 2012 Aug; 61(2):266-76. PubMed ID: 22594685
[TBL] [Abstract][Full Text] [Related]
34. Intraductal oncocytic papillary neoplasm of the bile duct: the first case of peribiliary gland origin.
Nakanishi Y; Zen Y; Hirano S; Tanaka E; Takahashi O; Yonemori A; Doumen H; Kawakami H; Itoh T; Nakanuma Y; Kondo S
J Hepatobiliary Pancreat Surg; 2009; 16(6):869-73. PubMed ID: 19322511
[TBL] [Abstract][Full Text] [Related]
35. Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct.
Jung G; Park KM; Lee SS; Yu E; Hong SM; Kim J
J Hepatol; 2012 Oct; 57(4):787-93. PubMed ID: 22634127
[TBL] [Abstract][Full Text] [Related]
36. Cholangiocarcinoma arising from intraductal papillary mucinous neoplasm of the bile duct.
Marincola P; Gonzalez RS; Shi C; Poulose B; Parikh A
Am Surg; 2015 Mar; 81(3):E102-3. PubMed ID: 25760180
[No Abstract] [Full Text] [Related]
37. Intraductal papillary neoplasm of the bile duct: review of updated clinicopathological and imaging characteristics.
Kim JR; Jang KT; Jang JY
Br J Surg; 2023 Aug; 110(9):1229-1240. PubMed ID: 37463281
[TBL] [Abstract][Full Text] [Related]
38. Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions.
Yeh TS; Tseng JH; Chen TC; Liu NJ; Chiu CT; Jan YY; Chen MF
Hepatology; 2005 Sep; 42(3):657-64. PubMed ID: 16116640
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic performance of CT and MRI in distinguishing intraductal papillary neoplasm of the bile duct from cholangiocarcinoma with intraductal papillary growth.
Liu Y; Zhong X; Yan L; Zheng J; Liu Z; Liang C
Eur Radiol; 2015 Jul; 25(7):1967-74. PubMed ID: 25716939
[TBL] [Abstract][Full Text] [Related]
40. Intraductal papillary neoplasm of the bile duct (IPN-B): also a disease of western Caucasian patients. A literature review and case series.
Mondal D; Silva MA; Soonawalla Z; Wang LM; Bungay HK
Clin Radiol; 2016 Jan; 71(1):e79-87. PubMed ID: 26493757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
